These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Monitoring and pharmacologic reversal of a nondepolarizing neuromuscular blockade should be routine. Miller RD; Ward TA Anesth Analg; 2010 Jul; 111(1):3-5. PubMed ID: 20576958 [No Abstract] [Full Text] [Related]
11. Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block. Kotake Y; Ochiai R; Suzuki T; Ogawa S; Takagi S; Ozaki M; Nakatsuka I; Takeda J Anesth Analg; 2013 Aug; 117(2):345-51. PubMed ID: 23757472 [TBL] [Abstract][Full Text] [Related]
12. Visual disturbance and residual paralysis. Lam AM Anesthesiology; 1997 Nov; 87(5):1257-9. PubMed ID: 9366487 [No Abstract] [Full Text] [Related]
13. [Neuromuscular rest blockades after a single dose of a mid-term muscle relaxant]. Schreiber JU Anaesthesist; 2004 Oct; 53(10):1006-8. PubMed ID: 15205835 [No Abstract] [Full Text] [Related]
15. [Prevention of undesirable effects during the use of non-depolarizing muscle relaxants]. Diefenbach C; Buzello W Klin Anasthesiol Intensivther; 1993; 42():132-51. PubMed ID: 8450621 [No Abstract] [Full Text] [Related]
16. Residual neuromuscular blockade in myotonic dystrophy: lessons unlearned and sugammadex. Stewart PA; Phillips S; de Boer HD Anaesth Intensive Care; 2011 Jul; 39(4):756-7; author reply 757. PubMed ID: 21823393 [No Abstract] [Full Text] [Related]
17. [Monitoring of neuromuscular block and prevention of residual paralysis]. Fuchs-Buder T; Meistelman C Ann Fr Anesth Reanim; 2009 Sep; 28 Suppl 2():S46-50. PubMed ID: 19887277 [TBL] [Abstract][Full Text] [Related]
20. Prolonged neuromuscular block with mivacurium in a patient with cholinesterase deficiency. Wong TK; Chen C; Liou SC; Lee YH; Huang CS J Formos Med Assoc; 2000 Aug; 99(8):656-8. PubMed ID: 10969512 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]